The many faces of macrophage activation

Journal of Leukocyte Biology

Volumn 73, Issue 2, 2003, Pages 209-212

  Mosser, David M ^a  

^a Bldg 142   (United States)

Author keywords

Alternatively activated macrophage; Autoimmunity; IFN ; IL 4; Immunoregulation; Type 2 activated macrophage

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; CELL SUBPOPULATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH2 CELL;

ANIMALS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES;

EID: 0037310024     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0602325     Document Type: Review

References (33)

1. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
2. Modolell, M., Corraliza, I. M., Link, F., Soler, G., Eichmann, K. (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25, 1101-1104.
3. Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C. E., Schledzewski, K., Goerdt, S. (2001) Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand. J. Immunol. 53, 386-392.
4. Gerber, J. S., Mosser, D. M. (2001) Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J. Immunol. 166, 6861-6868.
5. Anderson, C. A., Mosser, D. M. (2002) A novel phenotype for activated macrophages: the type II activated macrophage. J. Leukoc. Biol. 72, 101-106.
6. Aderson, C. F., Mosser, D. M. (2002) Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J. Immunol. 168, 3697-3701.
7. Nathan, C. (1991) Mechanisms and modulation of macrophage activation. Behring Inst. Mitt. Feb., 200-207.
8. Hibbs Jr., J. B. (2002) Infection and nitric oxide. J. Infect. Dis. 185 (Suppl. 1), S9-S17.
9. MacMicking, J., Xie, Q. W., Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
10. Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., Nathan, C. (2001) Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123-1140.
11. Mosser, D. M., Handman, E. (1992) Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J. Leukoc. Biol. 52, 369-376.
12. Ezekowitz, R. A., Gordon, S. (1984) Alterations of surface properties by macrophage activation: expression of receptors for Fc and mannoseterminal glycoproteins and differentiation antigens. Contemp. Top. Immunobiol. 13, 33-56.
13. Gruenheid, S., Gros, P. (2000) Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport. Curr. Opin. Microbiol. 3, 43-48.
14. Carlin, J. M., Borden, E. C., Sondel, P. M., Byrne, G. I. (1989) Interferoninduced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45, 29-34.
15. Dacosta, N. A., Kinare, S. G. (1991) Association of lung carcinoma and tuberculosis. J. Postgrad. Med. 37, 185-189.
16. Flavell, R. A. (2002) The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr. Top. Microbiol. Immunol. 266, 1-9.
17. Ho, A. S., Moore, K. W. (1994) Interleukin-10 and its receptor. Ther. Immunol. 1, 173-185.
18. Reed, S. G. (1999) TGF-beta in infections and infectious diseases. Microbes Infect. 1, 1313-1325.
19. Morrison, A. C., Correll, P. H. (2002) Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J. Immunol. 168, 853-860.
20. Huynh, M. L., Fadok, V. A., Henson, P. M. (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50.
21. Nandan, D., Knutson, K. L., Lo, R., Reiner, N. E. (2000) Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis. J. Leukoc. Biol. 67, 464-470.
22. Ting, L. M., Kim, A. C., Cattamanchi, A., Ernst, J. D. (1999) Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163, 3898-3906.
23. Goerdt, S., Orfanos, C. E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
24. Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., Murray, P. J. (2001) Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173-2177.
25. Schebesch, C., Kodelja, V., Muller, C., Hakij, N., Bisson, S., Orfanos, C. E., Goerdt, S. (1997) Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 92, 478-486.
26. Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C. D., Dippel, E., Kodelja, V., Orfanos, C. E. (1999) Alternative versus classical activation of macrophages. Pathobiology 67, 222-226.
27. Song, E., Ouyang, N., Horbelt, M., Antus, B., Wang, M., Exton, M. S. (2000) Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204, 19-28.
28. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., Wynn, T. A. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544.
29. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
30. Kodelja, V., Muller, C., Politz, O., Hakij, N., Orfanos, C. E., Goerdt, S. (1998) Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160, 1411-1418.
31. Raes, G., De Baetselier, P., Noel, W., Beschin, A., Brombacher, F., Hassanzadeh, G. G. (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71, 597-602.
32. Sutterwala, F. S., Noel, G. J., Clynes, R., Mosser, D. M. (1997) Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185, 1977-1985.
33. Sutterwala, F. S., Noel, G. J., Salgame, P., Mosser, D. M. (1998) Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188, 217-222.